Andrew W. Simonson

Andrew W. Simonson

Auto-generated profile, based on publicly available information

Andrew W. Simonson

University of Pittsburgh School of Medicine 1 Department of Microbiology and Molecular Genetics Pittsburgh, PA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CWCaylin G. Winchell
Caylin G. Winchell
SNSarah K. Nyquist
Sarah K. Nyquist
MCMichael C. Chao
Michael C. Chao
PMPauline Maiello
Pauline Maiello
AMAmy J. Myers
Amy J. Myers
JFJoAnne L. Flynn
JoAnne L. Flynn
The functional role of CD8+ lymphocytes in tuberculosis remains poorly understood. We depleted innate and/or adaptive CD8+ lymphocytes in macaques and showed that loss of all CD8α+ cells (using anti-CD8α antibody) significantly impaired early control of Mycobacterium tuberculosis (Mtb) infection, leading to increased granulomas, lung inflammation, and bacterial burden. Analysis of barcoded Mtb from infected macaques demonstrated that depletion of all CD8+ lymphocytes allowed increased establishment of Mtb in lungs and dissemination within lungs and to lymph nodes, while depletion of only adaptive CD8+ T cells (with anti-CD8β antibody) worsened bacterial control in lymph nodes. Flow cytometry and single-cell RNA sequencing revealed polyfunctional cytotoxic CD8+ lymphocytes in control granulomas, while CD8-depleted animals were unexpectedly enriched in CD4 and γδ T cells adopting incomplete cytotoxic signatures. Ligand-receptor analyses identified IL-15 signaling in granulomas as a driver of cytotoxic T cells. These data support that CD8+ lymphocytes are required for early protection against Mtb and suggest polyfunctional cytotoxic responses as a vaccine target.

6 February 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
ASAndrew W. Simonson
Andrew W. Simonson
JZJoseph J. Zeppa
Joseph J. Zeppa
ABAllison N. Bucsan
Allison N. Bucsan
SPSupriya Pokkali
Supriya Pokkali
FHForrest Hopkins
Forrest Hopkins
JFJoAnne L. Flynn
JoAnne L. Flynn
Tuberculosis (TB) is a major health burden worldwide despite widespread intradermal (ID) BCG vaccination in newborns. We previously demonstrated that changing the BCG route and dose from 5 × 105 CFUs ID to 5 × 107 CFUs i.v. resulted in prevention of Mycobacterium tuberculosis (Mtb) infection and TB disease in highly susceptible nonhuman primates. Identifying immune mechanisms protection following i.v. BCG will facilitate development of more effective vaccines against TB. Here, we depleted lymphocyte subsets prior to and during Mtb challenge in i.v. BCG–vaccinated macaques to identify those necessary for protection. Depletion of adaptive CD4 T cells, but not adaptive CD8αβ T cells, resulted in loss of protection with increased Mtb burdens and dissemination, indicating that CD4 T cells are critical to i.v. BCG–mediated protection. Depletion of unconventional CD8α-expressing lymphocytes (NK cells, innate T cells, and CD4+CD8α+ double-positive T cells) abrogated protection in most i.v. BCG–immunized macaques, supporting further investigation into which of these cell subsets contribute to protection after vaccination.

4 January 2021 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
ASAndrew W. Simonson
Andrew W. Simonson
AMAgustey S. Mongia
Agustey S. Mongia
MAMatthew Aronson
Matthew Aronson
JAJohn N. Alumasa
John N. Alumasa
DCDennis C. Chan
Dennis C. Chan
SMScott H. Medina
Scott H. Medina

10 January 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
ASAlexander A. Smith
Alexander A. Smith
HSHongwei Su
Hongwei Su
JWJoshua Wallach
Joshua Wallach
YLYao Liu
Yao Liu
PMPauline Maiello
Pauline Maiello
JFJoAnne L. Flynn
JoAnne L. Flynn

1 May 2023 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ASAndrew W Simonson
Andrew W Simonson
MCMichael Chao
Michael Chao
FHForrest Hopkins
Forrest Hopkins
RKRyan Kelly
Ryan Kelly
MCMike Chase
Mike Chase
JFJoAnne L Flynn
JoAnne L Flynn
Significance: Meta-analysis of human data suggests that M. tuberculosis (Mtb) infection confers protection against subsequent exposure. Our lab demonstrated this in a controlled experimental system using non-human primates. As the best model for natural immunity against TB, it is crucial to explore the mechanisms behind concomitant immunity. We hypothesized that CD8+ T cells would play a key role in preventing disease following secondary challenge. Methods: Chinese cynomolgus macaques were challenged intrabronchially with a genetically barcoded library (LibP) of Mtb, allowing an adaptive response to develop. After clearing the primary infection with anti-TB drugs, CD8+ cells were depleted in half of the cohort. This was followed by a secondary Mtb challenge with a unique barcoded library (LibS). PET-CT scans enabled tracking of lesions that developed after secondary exposure. All granulomas and lymph nodes were isolated at necropsy and sequenced to determine the bacterial source (LibP vs. LibS). Spectral flow cytometry was used to analyze lymphocytes in individual tissues isolated at necropsy, examining the cytokines and other effector molecules produced by that may drive protection in the presence and absence of CD8+ cells. Results: Our data support that CD8 depleted animals lose the ability to contain Mtb after reinfection. CD8+ cells do not appear to prevent establishment of infection independently. However, the bottleneck restricting dissemination, especially to lymph nodes, is loosened in the absence of this population. Thus, CD8+ lymphocytes are critical to immunological protection against Mtb and should be considered as a key component for vaccine and host directed therapy development. Supported by NIH IMPAc-TB (HI-IMPACT) and T32 (5T32AI089443-13)